- And… We’re Back.
- Transitions
- Bioethical Marching Orders
- FDA Intervention Shelves Plan for Drugstore Genome Tests
- The Boons of an NIH Boost
- Crime Lab DNA Databases Under the Microscope
- Domes of Carbon Over U.S. Cities Damage Urban Health
- FDA Rules for Cigarettes Are a Victory for Public Health, for Science (and for the Earth’s Climate?)
- Legislation Introduced to Codify Stem Cell Rules
- Commissioner Enhances FDA’s Commitment to Personalized Medicine
- Perfecting Policy on Stem Cells
- NIH and FDA Aim to Retool Regulatory Science
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
Data Bank: U.S. Reproductive Biotechnology Regulation Falls Behind
Last week, Jonathan Moreno called for international standards governing reproductive technologies. But if we want to ensure that frightening decisions about genetic modification are not being made around the world, we should first focus on developing strict regulatory standards here at home.
At the moment, the United States has no existing federal policies on a host of reproductive technologies, including techniques at the center of bioethical debates, from reproductive cloning to preimplantation genetic diagnosis. The latter is a technology that made news last week when a Los Angeles reproductive clinic, Fertility Institutes, announced that it will soon offer services that will allow parents to choose some of an embryo’s physical traits like eye color, hair color, and complexion.
Richard Hayes, of the Center for Genetics and Society, surveyed human biotechnology policies around the world for Science Progress last year, and this map captures his research on regulations in place across the planet:
It suffices to say that the United States has fallen behind the rest of the world in its regulation of reproductive biotechnologies. Many peer nations, including England, France, Japan and Australia, socially prohibit sex selection technologies. However, there are currently no U.S. federal regulations on this controversial technique. In fact, a 2006 survey by the Genetics and Public Policy Center at Johns Hopkins University found that 42 percent of 137 clinics in the United States that offer preimplantation genetic diagnosis also offer a gender-selection service. The United States does not even have any regulation in place governing inheritable genetic modification in humans, a technique used in animal experimentation that determines phenotypic traits passed on to children. Dozens of industrialized countries in Europe and Asia strongly prohibit the technology.
The science behind these biotechnologies is moving fast. It’s time for the policy to catch up.
[Note: The map above displays data available in the Center for Genetics and Society’s BioPolicyWiki as of October 28, 2008.]
Comments on this article
